Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AegirBio focuses on RadX project, will not uphold CE-markings for the MagniaReader TDM tests

AegirBio, a leading innovator in saliva-based diagnostics solutions, today announces that it will focus towards pioneering advancements in Therapeutic Drug Monitoring (TDM) through the development of a groundbreaking platform under the RadX initiative, coupled with a robust business development strategy.In line with this decision, AegirBio will continue to offer its current MagniaReader and the two TDM tests for the MagniaReader, albeit exclusively for research purposes and will thus not uphold the CE markings for the said PoC tests for infliximab (Remicade) and natalizumab (Tysabri). These

MTG increases ownership in PlaySimple to 100%

Modern Times Group MTG AB (publ) (“MTG”) today announced that it now owns 100% of its Indian casual gaming studios PlaySimple, in line with the timeline to full ownership announced at the time of the acquisition in 2021. At this stage MTG has not been able to transfer Class B shares (currently held by MTG as Class C shares ) to the founders of PlaySimple as per the original purchase agreement. MTG continues to strongly believe in the long-term benefits of having PlaySimple’s founders hold shares in the group, and intends to continue exploring options to achieve this.In order to explore

Invitation to presentation of BioArctic’s third quarter report for July - September 2023 on November 8 at 9.30 a.m. CET

Stockholm, Sweden, November 1, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B)will publish the company’s third quarter report for July – September 2023 onWednesday, November 8, 2023, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on November 8, at 09:30 CET, where Gunilla Osswald, CEO, and Anders Martin-Löf, CFO, will present BioArctic and comment on the third quarter report for July – September 2023, followed by a Q&A-session. If you wish to participate via webcast, please use

The subscription price for the warrants of series TO3 in PEPTONIC medical AB has been determined to SEK 0.05 and the exercise period starts November 2, 2023

PEPTONIC medical AB ("Peptonic" or "the Company") completed a rights issue of units on Spotlight Stock Market in January 2023. Each warrant of series TO3 entitles to subscribe for one (1) new share in the Company. The exercise price for the warrants of series TO3 have been determined to 70 percent of the volume-weighted average price in the Company’s share on Spotlight Stock Market during the measurement period, which ran from and including October 18, 2023, up to and including October 31, 2023, however not higher than SEK 0.12 and not less than the quota value of the Company’s shares. During

YIT Corporation’s financial reporting and Annual General Meeting in 2024

YIT Corporation Stock Exchange Release 1 November 2023 at 09:30 a.m.YIT Corporation’s financial reporting and Annual General Meeting in 2024 YIT will publish the Financial Statements Bulletin for 2023 on Friday, 9 February 2024. Financial Statements 2023 will be published during week 8/2024 at the latest. In addition, YIT will publish two interim reports and a half-year report in 2024: · Interim Report for January-March on Tuesday, 30 April 2024 · Half-year Report for January-June on Friday, 26 July 2024 · Interim Report for January-September on Thursday, 31 October 2024

Metso's financial reporting and Annual General Meeting in 2024

Metso Corporation’s stock exchange release on November 1, 2023, at 9:30 a.m. EETMetso Corporation will publish its financial reports in 2024 as follows: · Financial Statements Review for 2023 on February 16, 2024 · Annual Report for 2023 during the week of March 18, 2024 · Interim Report for January - March 2024 on April 25, 2024 · Half-Year Financial Report for January - June 2024 on July 24, 2024 · Interim Report for January – September 2024 on October 24, 2024 The Annual General Meeting is planned to be held on April 25, 2024. Metso’s Board of Directors will summon

Archer Limited: Invitation to Third Quarter 2023 Earnings Release Call

Hamilton, Bermuda (November 1[st], 2023) Archer Limited’s third quarter 2023 results are scheduled to be released on November 3[rd], 2023, before the start of trading on Oslo Stock Exchange.  In connection with the earnings release, a presentation will be held at 09:00 am CET on November 3[rd], 2023. To follow the presentation, the following options are available: A. Webcast To register for the webcast please go to https://events.q4inc.com/attendee/991788945 B. Conference call To access the call, which is open to the public, please dial in at the participant telephone

BioStock: New CMO strengthens Lipum ahead of continued clinical development

Lipum is in the final stages of the clinical phase I study with SOL-116. In parallel, the company is preparing for the next step, a phase II study in rheumatoid arthritis. To strengthen its team for this, the company has recently recruited Karin Franck-Larsson as CMO. BioStock had the opportunity to interview Karin about her background and her expectations for her new role.Read the full article at biostock.se: https://www.biostock.se/en/2023/11/new-cmo-strengthens-lipum-ahead-of-continued-clinical-development/ This is a press release from BioStock - Connecting Innovation & Capital.

Photocure ASA: Invitation to presentation of third quarter 2023 financial results

Oslo, Norway, 1 November 2023: Photocure ASA (Photocure, PHO: OSE) will announce the third quarter 2023 financial results on Wednesday 8 November 2023 at 08:00 CET and will present a live webcast at 14:00 CET the same day.The quarterly report and presentation will be published at 08:00 CET and will be publicly available at www.photocure.com. The investor presentation will be streamed live and be hosted by Dan Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event. The presentation is scheduled to conclude at 14:45

AstraZeneca cell & gene therapy deal w/ Cellectis

01 November 2023 AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions Collaboration leverages the Cellectis gene editing technologies and manufacturing capabilities, to develop up to 10 novel cell and gene therapy candidate products AstraZeneca today announced a collaboration and investment agreement with Cellectis, a clinical-stage biotechnology company, to accelerate the development of next generation therapeutics in areas of high unmet need, including oncology, immunology and rare diseases. Under

The exercise period for warrants TO5 in Dicot starts today

Press release: Uppsala, Sweden, November 1, 2023.  Today, November 1, 2023, the exercise period for warrants of series TO5 in Dicot AB (publ), which were included in the unit issue in January 2023, begins. Subscription period lasts until November 15, 2023.Each warrant of series TO5 entitles the holder to subscribe to one new share during the period November 1-15, 2023, to the exercise price of SEK 0.086. If all warrants are exercised, Dicot will receive approximately SEK 19.4 million before issuing costs. The issue in January with its options TO4 in June and TO5 in November are all

Metso receives orders for three copper anode casting shops

Metso Corporation’s press release on November 1, 2023, at 09:00 a.m. EETMetso has received orders for three Outotec Anode Casting Shops from major copper producers in Japan and China. The total value of the orders is EUR 13 million. One of the orders has been booked in the Minerals segment’s 2023 fourth quarter orders received and two in the third quarter orders received. In each of the projects, Metso’s scope of delivery includes anode casting shops with engineering and state-of-the-art technology. “Today, most of the world’s copper anodes are produced with Metso’s proprietary anode

Camurus to present at Jefferies 2023 Healthcare Conference London

Lund, Sweden — 1 November 2023 — Camurus (Nasdaq Stockholm; CAMX), a commercial-stage pharmaceutical company developing innovative medications for severe and chronic diseases, today announced that Fredrik Tiberg, President and Chief Executive Officer, will participate in a fireside chat about the company’s business progress and R&D pipeline developments at Jefferies 2023 Healthcare Conference in London on 15 November at 8:30-8:55 am local time (GMT). A live webcast of the presentation can be accessed via: https://wsw.com/webcast/jeff287/camx.st/2248776 For more informationFredrik

Betolar accelerates the commercialisation of its mining solutions

Press release1.11.2023, Levi, Finland Betolar accelerates the commercialisation of its mining solutions Betolar accelerates the commercial utilisation of its construction materials technology in the mining industry, which generates large quantities of currently unused side-stream materials. Betolar has become a member of Mining Finland, a cooperation association for mining ecosystem actors in Finland. "There is huge potential to exploit the by-products of the mining industry, with a significant commercial value. With our technology, the side streams can be used as

Heimstaden Appoints Rita Berg Hansen as Group Director of Privatisation

Heimstaden Bostad announced in the Q3 report a commitment to sell a part of its portfolio unit by unit to private homeowners (privatisation). Rita Berg Hansen has been appointed as the Group Director of Privatisation and will lead this strategic unit from 1 November, driving the expansion of privatisation across our markets.The Board-approved Privatisation Plan targets SEK 20 billion book value sales by 2025 with a 20% premium to book value. Initial results are promising, with a 31% premium on book value from the sale of 127 units year-to-date. Following the pilot phase, the Plan will

DDM announces changes to Board of Directors

DDM Debt AB (publ) (Nasdaq Stockholm: DDM Debt 2026) (“DDM Debt”) announces that Andreas Tuczka, member of the Board of Directors of DDM Debt, has informed the Board of Directors that he will leave his assignment and his other Board positions in the DDM group with immediate effect to focus on other engagements. Keith Halsey will join the Board of Directors of DDM Debt, bringing a wealth of experience to DDM.   Jörgen Durban, Chairman of the Board of DDM Debt says “I want to thank Andreas for his time as a valued member of the Board, during which he has made a significant contribution to

SaltX Technology Holding AB Interim Report Q3 - 2023

SaltX Technology is a Swedish Greentech company that develops and markets sustainable technology that benefits customers, the climate, and society. The company today issues its Interim Report Q3 - 2023."During the quarter, the trust in us as a company, our technology, and its potential has strengthened even more. We are well on our way to becoming a significant industrial player and a strong driving force in the industry's transformation."  - Carl-Johan Linér, CEO SaltX Technology Presentation of Interim report The report is presented in a video interview where SaltX CEO, Carl-Johan

Nilar International AB Interim Report Q3 2023

Nilar launches next-generation battery in the Netherlands.April – September 2023 in summary · Net sales, MSEK 1.2 (1.2). · Delivered batteries 190 (68). · Gross profit MSEK -104.0 (-31.3). · EBITDA1 MSEK -46.5 (-38.0). · Operating profit (EBIT) MSEK -126.1 (-53.8). · Profit for the period MSEK -130.7 (-63.8). · Earnings per share SEK -0.41 (-0.21). January – September 2023 in summary · Net sales, MSEK 6.5 (-1.2). · Delivered batteries 426 (572). · Gross profit MSEK -170.9 (-107.1). · EBITDA1 MSEK -130.3 (-128.8). · Operating profit (EBIT) MSEK -249.

Neste plans to simplify its organizational structure to improve efficiency and to strengthen long-term competitiveness

Neste Corporation, Stock Exchange Release, Insider Information, 1 November 2023 at 9 a.m. (EET)Neste plans to simplify its organizational structure and its operational model to secure the execution of its growth strategy with improved cost-efficiency and to strengthen its long-term competitiveness. With the planned changes and the simplified structure, Neste aims to strengthen accountabilities and efficient decision making.Renewable Aviation, Renewable Road Transportation and Renewable Polymers and Chemicals business units will be merged into one Renewable Products business unit

CHIEF INFORMATION OFFICER, CHARLOTTE SVENSSON, TO LEAVE SAS

SAS announces today that Charlotte Svensson, Executive Vice President and Chief Information Officer, has decided to leave the company.“Charlotte has been the driver of new investments in Artificial Intelligence and automation and together with her team, she developed the new award-winning SAS app. I would like to thank Charlotte for our close cooperation and her dedication to the company,” says Anko van der Werff, SAS President & CEO. Charlotte Svensson will leave SAS in March 2024. The recruitment process for her successor has started to ensure a smooth transition.

Proact receives award for security and data centres

Proact was recognised by Dell with an award for its strong focus on data protection and data centre sales during the Swedish Dell Technology Forum.Proact, Europe's leading independent provider of data centre and cloud services, was delighted to receive the Excellence in Security partner award. with the motivation: "Proact has developed an impressive concept together with Dell with a strong focus on data protection and has embraced Dell's entire security concept. For a long time, Proact has worked closely with both customers and Dell to minimise data protection vulnerabilities. Proact also

Navamedic ASA: Record high quarter with above 50 percent growth

Oslo, 1 November 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, today announces its results for the third quarter of 2023. With growth across the company’s three core product areas, Prescription Drugs (RX), Consumer Health and Hospital, year to date, Navamedic has delivered another record quarter. Revenues for the third quarter amounted to NOK 141 million, corresponding to a 51.9 per cent increase Year-over-Year.The company’s gross margin was 37.6 per cent, down from 42.5 per cent in the third quarter of

Metacon publishes interim report for Q3 2023

We see a strong increase in interest in our systems and solutions as a direct result of the inauguration of the filling station in Älghult in Småland in August. The filling station will serve both heavy vehicles and passenger cars with green hydrogen from local wind power electricity and was a historic milestone for Metacon in our long-term company building, comments Christer Wikner, President and CEO. For the full CEO-comment, see the Interim report in its entirety. Quarter for the Group July-September 2023 · Revenues amounted to SEK 21,5 (21,8) million. · Earnings before

YIT’s Interim Report January-September 2023

YIT Corporation Stock Exchange Release 1 November 2023 at 09:00 a.m.YIT’s Interim Report January-September 2023  Operating cash flow for the quarter improved significantly from the comparison period; net debt remained stable from the previous quarter. Revenue was stable at EUR 553 million (560), while adjusted operating profit decreased to EUR 16 million (21).  Third quarter 2023 in brief  ·The order book was EUR 3,391 million (30 Jun 2023: 3,540), the decrease was due to the lower number of consumer apartment start-ups in Housing. The order book in Business Premises remained

There are no items matching the current filter
There are no more items matching the current filter
Back to top